Today: 7 February 2026
Subscribe
Browse Category

NYSE:JNJ News 14 January 2026 - 18 January 2026

Trump’s Greenland tariff threat sets up a tense week for global stocks

Trump’s Greenland tariff threat sets up a tense week for global stocks

President Donald Trump threatened 10% tariffs on eight European countries tied to Greenland, escalating to 25% by June if no deal is reached. The S&P 500 closed nearly flat at 6,940.01, while the Dow and Nasdaq also posted slight losses. Europe’s STOXX 600 ended flat, and China’s regulator announced tighter market controls. U.S. markets will close Monday for Martin Luther King Jr. Day.
18 January 2026
···
Johnson & Johnson stock heads into earnings after a mild dip — what could move JNJ next

Johnson & Johnson stock heads into earnings after a mild dip — what could move JNJ next

Johnson & Johnson shares closed down 0.4% at $218.66 Friday ahead of the Martin Luther King Jr. Day market holiday. The S&P 500 health care sector fell 0.8%. J&J reports fourth-quarter results Wednesday, Jan. 21, with investors focused on earnings and 2026 guidance. The NYSE will reopen Tuesday after the holiday.
18 January 2026
·······
Supreme Court Fed showdown, Davos and China GDP: what to watch in global markets next week

Supreme Court Fed showdown, Davos and China GDP: what to watch in global markets next week

The U.S. Supreme Court will hear arguments Wednesday on President Trump’s effort to remove Fed Governor Lisa Cook. Stocks ended the week lower, with the S&P 500 at 6,940.01 and Brent crude at $64.13. China releases GDP data as Davos opens, while Japan nears a possible snap election. Prime Minister Takaichi may suspend Japan’s 8% food sales tax, risking a 5 trillion yen revenue hit.
18 January 2026
····
Johnson & Johnson stock slips — what traders watch before JNJ earnings

Johnson & Johnson stock slips — what traders watch before JNJ earnings

Johnson & Johnson shares closed down 0.41% at $218.66 Friday and were flat after hours. The company reports fourth-quarter earnings January 21, with investors watching for updates on drug approvals and MedTech growth. FDA fast-track reviews and consumer-health deals remain in focus. Kenvue, spun off from J&J, faces a key shareholder vote January 29 on its sale to Kimberly-Clark.
17 January 2026
··
Johnson & Johnson stock rises after Tecvayli trial win as JNJ eyes earnings

Johnson & Johnson stock rises after Tecvayli trial win as JNJ eyes earnings

Johnson & Johnson shares rose 2.3% to $218.55 in after-hours trading Wednesday after reporting its Tecvayli drug cut the risk of disease progression or death by 71% in a late-stage multiple myeloma trial. An independent committee recommended unblinding the study. Full results will be presented at an upcoming medical meeting. Investors await the company’s quarterly results next week.
15 January 2026
···
Johnson & Johnson stock rises on Auris court win as talc fight and Jan. 21 earnings loom

Johnson & Johnson stock rises on Auris court win as talc fight and Jan. 21 earnings loom

Johnson & Johnson shares rose 1.9% to $217.80 by late morning Wednesday, outperforming a 1% drop in the S&P 500. Delaware’s Supreme Court threw out part of a ruling tied to Auris Health merger payments, possibly cutting damages by hundreds of millions. Legal battles over talc litigation continue. J&J’s Q4 earnings call is scheduled for Jan. 21.
14 January 2026
······
1 2 3 4 5 6 … 11

Stock Market Today

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

7 February 2026
Google raised its 2026 capital expenditure forecast to $175 billion–$185 billion, with most spending expected on data-center chips. Broadcom shares rose about 2% after the announcement, while Nvidia and AMD slipped. Jefferies reiterated a buy rating on Broadcom, maintaining a $500 price target, implying a 62% upside from Wednesday’s close.
No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

7 February 2026
The IRS has not announced new federal stimulus payments for February 2026, and Congress has not approved fresh checks. Trump told NBC he is considering $2,000 tariff rebate checks but has not committed, saying any payout would likely come later in 2026. The IRS warns taxpayers to ignore texts and emails about “stimulus payments” and verify notices through official channels.
Go toTop